Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Portal Hypertension and Hepatosplenomegaly: A Case Report, Study notes of Medicine

A case report of a 22-year-old man with a history of sarcoidosis who presented with possible hepatosplenomegaly. The authors used liver/spleen scintigraphy to evaluate the patient's liver function and diagnose portal hypertension. The causes, symptoms, and diagnostic methods of portal hypertension and hepatosplenomegaly, as well as the potential complications and management strategies.

What you will learn

  • What are the potential complications and management strategies for patients with portal hypertension?
  • How is portal hypertension diagnosed?
  • What is portal hypertension and what are its causes?

Typology: Study notes

2021/2022

Uploaded on 09/12/2022

gerrard_11
gerrard_11 🇬🇧

4.3

(6)

234 documents

1 / 3

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Portal Hypertension as Portrayed
by
Marked
Hepatosplenomegaly: Case Report
Robin A. Greene
Yale
University Medical Center/Yale New Haven Hospital, New Haven, Connecticut
The liver is vulnerable
to
a host
of
disease processes, includ-
ing portal hypertension. This is a severe hepatic condition in
which the liver is subject to numerous imbalances: increased
hepatic blood
flow,
increased portal vein pressure due to extra-
hepatic portal vein obstruction, and/or increases in hepatic
blood flow resistance (J). Although many disease states may
be responsible for the development
of
portal hypertension, it
is most commonly associated with moderately severe
or
ad-
vanced cirrhosis (2). Advanced, untreated portal hypertension
may
cause additional complications such as hepatosplenomeg-
aly, gastrointestinal bleeding, and ascites {1).
CASE
REPORT
The patient was a 22-yr-old man with a long history
of
sar-
coidosis, a chronic granulomatous disease process
of
unknown
etiology. Sarcoidosis is characterized
by
the formation
of
tubercle-like lesions in affected organs, usually the skin, lymph
nodes, lungs, and bone marrow (3). This patient had confirmed
pulmonary, eye, and dermatologic involvement. Because
of
persistent elevation in liver function tests, the clinicians be-
lieved that sarcoid involvement
of
the liver was present as well.
An abdominal exam revealed possible hepatosplenomegaly,
and a liver/spleen scan was requested.
After the intravenous administration
of
6 mCi (222 MBq
of
technetium-99m (
99
mTc)
sulfur colloid, multiple planar
images
of
the liver and spleen were obtained with a scintillation
camera. The images were collected for 750,000 counts each,
employing a 20% window that was centered on the
140
keY
photopeak
of
99
mTc.
High resolution collimation was used.
Image evaluation (Fig.
1)
revealed that both the liver and
spleen were enlarged (the spleen measured 23 em in its longest
dimension). No focal defects were apparent in the images.
There was minimal shift
of
radiocolloid from the liver to the
spleen.
The patient did not agree to a liver biopsy so there was
no confirmed diagnosis, although infectious hepatitis was
suspected based on all
of
the other tests performed.
DISCUSSION
In normal persons, the distribution ratio
of
99
mTc
radio-
colloid between the liver and spleen is about 5.5:1. In the
presence
of
portal hypertension this ratio decreases
or
may
For reprints contact:
Robin
A.
Greene,
Yale
University School of Medicine,
TIMI Core
Lab,
Fitkin
2,
Room
206,
333
Cedar Street,
New
Haven,
Cf
06504.
VOLUME
15,
NUMBER
4,
DECEMBER 1987
be reversed in more severe cases (2). This individual's
99
mTc
sulfur colloid images demonstrated the combination
of
an
enlarged liver and spleen, with homogeneous distribution of
radiocolloid. A slight shift in activity to the spleen was also
noted. The clinician's diagnosis based on these findings sug-
gested diffuse hepatocellular disease. The confirmation
of
this
diagnosis will require subsequent testing for other processes
such as infectious hepatitis, which has been found to produce
TABLE
1.
Causes of Hepatosplenomegaly
Common
Metastatic tumors
Fatty infiltration
Hepatitis
Cirrhosis
Congestive heart failure
Abscess
Leukemia
Lymphoma
Normal variants-Reidel's lobe
Uncommon
Infection
Tuberculosis
Infectious mononucleosis
Hemochromatosis
Chronic passive congestion
Trauma
Hemolysis
Erythroblastosis fetalis
Chronic hemolytic anemia
Drugs
Phenobarbital
Diphenylhydantoin
Sulfonamides
Acetaminophen
Tetracycline
Corticosteroids
Methotrexate
Androgens
Primary tumors
Cysts (hydatid)
Rare
Inherited metabolic disorders
with hepatic involvement
Wolman's disease
Glycogen storage disease
Rare (continued)
Wilson's disease
Gaucher's disease
M ucopolysaccharidosis
Niemann-Pick disease
Gangliosidosis
Alpha 1-antitrypsin deficiency
Hepatic porphyrias
Cystic fibrosis
Histiocytosis X
Galactosemia
Acromegaly
Polycystic disease
Inflammatory noninfective
disorders
Sarcoidosis
Granulomatous hepatitis
Juvenile rheumatoid arthritis
Kwashiorkor
Biliary obstruction
Amyloidosis
Vascular disorders
Hereditary hemorrhagic
telangiectasia
Multinodular
hemangiomatosis
Cavernous hemangiomas
Budd-Chiari syndrome
Jamaican vomiting disease
Infection
Congenital
or
postnatal
syphilis
Schistosomiasis
Amebiasis
Actinomycosis
Hydatid cyst
Weil's disease
Proxysmal nocturnal
hemoglobinuria
187
pf3

Partial preview of the text

Download Portal Hypertension and Hepatosplenomegaly: A Case Report and more Study notes Medicine in PDF only on Docsity!

Portal Hypertension as Portrayed by Marked

Hepatosplenomegaly: Case Report

Robin A. Greene

Yale University Medical Center/Yale New Haven Hospital, New Haven, Connecticut

The liver is vulnerable to a host of disease processes, includ- ing portal hypertension. This is a severe hepatic condition in which the liver is subject to numerous imbalances: increased hepatic blood flow, increased portal vein pressure due to extra- hepatic portal vein obstruction, and/or increases in hepatic blood flow resistance (J). Although many disease states may be responsible for the development of portal hypertension, it is most commonly associated with moderately severe or ad- vanced cirrhosis (2). Advanced, untreated portal hypertension may cause additional complications such as hepatosplenomeg- aly, gastrointestinal bleeding, and ascites {1).

CASE REPORT

The patient was a 22-yr-old man with a long history of sar- coidosis, a chronic granulomatous disease process of unknown etiology. Sarcoidosis is characterized by the formation of tubercle-like lesions in affected organs, usually the skin, lymph nodes, lungs, and bone marrow (3). This patient had confirmed pulmonary, eye, and dermatologic involvement. Because of persistent elevation in liver function tests, the clinicians be- lieved that sarcoid involvement of the liver was present as well. An abdominal exam revealed possible hepatosplenomegaly, and a liver/spleen scan was requested. After the intravenous administration of 6 mCi (222 MBq of technetium-99m (^99 mTc) sulfur colloid, multiple planar images of the liver and spleen were obtained with a scintillation camera. The images were collected for 750,000 counts each, employing a 20% window that was centered on the 140 keY photopeak of 99 mTc. High resolution collimation was used. Image evaluation (Fig. 1) revealed that both the liver and spleen were enlarged (the spleen measured 23 em in its longest dimension). No focal defects were apparent in the images. There was minimal shift of radiocolloid from the liver to the spleen. The patient did not agree to a liver biopsy so there was no confirmed diagnosis, although infectious hepatitis was suspected based on all of the other tests performed.

DISCUSSION

In normal persons, the distribution ratio of 99 mTc radio- colloid between the liver and spleen is about 5.5:1. In the presence of portal hypertension this ratio decreases or may

For reprints contact: Robin A. Greene, Yale University School of Medicine, TIMI Core Lab, Fitkin 2, Room 206, 333 Cedar Street, New Haven, Cf 06504.

VOLUME 15, NUMBER 4, DECEMBER 1987

be reversed in more severe cases (2). This individual's 99 mTc sulfur colloid images demonstrated the combination of an enlarged liver and spleen, with homogeneous distribution of radiocolloid. A slight shift in activity to the spleen was also noted. The clinician's diagnosis based on these findings sug- gested diffuse hepatocellular disease. The confirmation of this diagnosis will require subsequent testing for other processes such as infectious hepatitis, which has been found to produce

TABLE 1. Causes of Hepatosplenomegaly

Common Metastatic tumors Fatty infiltration Hepatitis Cirrhosis Congestive heart failure Abscess Leukemia Lymphoma Normal variants-Reidel's lobe

Uncommon Infection Tuberculosis Infectious mononucleosis Hemochromatosis Chronic passive congestion Trauma Hemolysis Erythroblastosis fetalis Chronic hemolytic anemia Drugs Phenobarbital Diphenylhydantoin Sulfonamides Acetaminophen Tetracycline Corticosteroids Methotrexate Androgens Primary tumors Cysts (hydatid)

Rare Inherited metabolic disorders with hepatic involvement Wolman's disease Glycogen storage disease

Rare (continued) Wilson's disease Gaucher's disease M ucopolysaccharidosis Niemann-Pick disease Gangliosidosis Alpha 1-antitrypsin deficiency Hepatic porphyrias Cystic fibrosis Histiocytosis X Galactosemia Acromegaly Polycystic disease Inflammatory noninfective disorders Sarcoidosis Granulomatous hepatitis Juvenile rheumatoid arthritis Kwashiorkor Biliary obstruction Amyloidosis Vascular disorders Hereditary hemorrhagic telangiectasia Multinodular hemangiomatosis Cavernous hemangiomas Budd-Chiari syndrome Jamaican vomiting disease Infection Congenital or postnatal syphilis Schistosomiasis Amebiasis Actinomycosis Hydatid cyst Weil's disease Proxysmal nocturnal hemoglobinuria

similar scintigraphic appearances. Infiltrative processes such as sarcoidosis, leukemia, or intrahepatic lymphoma (4) may demonstrate hepatosplenomegaly, but there is less intense uptake of the colloid in the spleen. Additional testing to aid in differential diagnosis may include abdominal radiographic evaluation in an attempt to visualize calcification of the portal vein to confirm or evaluate the extent of the hepatosplenomegaly (1). Computed tomography and ultrasound scanning may also be employed. Clinicians should use a combined approach in the diagnosis and management of these patient because of the many disease states in which hepatosplenomegaly may be present (Table 1) (4).

Patients with portal hypertension are hospitalized and moni- tored for some of the complications that may accompany the disease state. Should the patient present with acute upper gastrointestinal bleeding, blood transfusions may be clinically indicated. A hospitalized patient may receive the specialized management available for the various complications that may accompany portal hypertension. Accurate diagnosis is essential to provide the clinician with appropriate methods in managing the patient's disease and complications that may stem from the primary disease. Liver/ spleen scintigraphic imaging can play a vital role in helping to piece together the sometimes complicated puzzle of portal

JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY